Contact

T-Cell Assay Services

JPT Peptide Technologies is offering a complete T-cell assay portfolio for

  • T cell vaccine target identification
  • Deep T cell epitope discovery
  • Neo-epitope qualification
  • T-cell epitope mapping
  • Antigen discovery

JPT Peptide Technologies can now offer you a comprehensive service ranging from the early project design to its final execution, including:

  • Assistance with target protein/subunit selection
  • Intelligent sequence analysis/bioinformatics
  • Peptide library design including the coverage of known sequence variations
  • Peptide synthesis, peptide pooling, matrix pool design & plating
  • T cell assays (e.g. Elispot, Flow-cytometry, MHC multimer staining and others)
  • Final report/data summary

Available T Cell Assays

  • Flow Cytometry
  • Multimer staining
  • Intracellular cytokine staining (ICS)
  • B cell Elispot
  • T cell Elispot

Your advantages in choosing JPT Peptide Technologies as a partner:

  • Reliable and robust workflows
  • All in one service
  • Stringent quality control
  • Competitive pricing
  • Freedom to focus your valuable resources elsewhere
  • ISO 9001:2015 certified quality management system 

Application Notes with T-Cell Assay Services

"Developing Multi-HIV Antigen Specific T-Cells as a Component of a Cure Strategy"
by Sharon Lam, Conras Russell Cruz and Catherine Bollard
"Cytomegalovirus Protein Spanning PepMix™ Peptide Pools to Discover Changes in T cell immunity in the Aging Population"
by F. Kern, Brighton and Sussex Medical School, UK
"T cell Therapy for Viral Infections After Hematopoietic Stem Cell Transplant"
by A. M. Leen, Baylor College of Medicine TX, USA
"Qualification and Use of Peptide Libraries for Clinical Trial Immunomonitoring"
by Josephine H Cox & Peter Hayes, The International AIDS Vaccine Initiative, London, GB

Request a price for T-Cell Assay Services

News Highlights

Quality Assurance

All production is performed according to ISO 9001:2015 standards

Stay in touch and be the first to receive the latest news!